Acarix resolves on a partially guaranteed rights issue of approximately SEK 52.9 million.

On a Mission to Listen to Millions of Hearts

Introducing CADScor®System — an AI-powered acoustic diagnostic aid to rule out coronary artery disease in 10 minutes.*

Learn more about CADScor®System

Use CADScor®System to Rule-Out CAD in Patients Experiencing Chest Pain or Shortness of Breath*

Non-invasive and radiation-free assessment for early rule-out of CAD.

Can help save costs of more advanced CAD diagnostics in up to 35% of patients.¹

Rapid and easy-to-use, with clear results in 10 minutes.

Rule-Out CAD in Just 10 Minutes with 96% Confidence¹

CADScor®System is a point-of-care diagnostic aid that uses highly sensitive acoustics and advanced AI to analyze the patient's coronary blood flow.² In just 10 minutes, it calculates a patient-specific CAD-score, indicating the patient’s risk of coronary stenosis. CADScor®System has been used in 20,000 patient assessments³ and has CE-marking and FDA De Novo clearance.

Learn more about CADScor®System
Physicians’ Experiences Using CADScor®System
Explore customer feedback
Schedule a Demo of CADScor®System

Schedule a free demo of CADScor®System and learn how to rule out low-risk CAD patients in 10 minutes.

Book a CADScor®System demo

Latest News

See all news
November 24, 2022

Helen Ljungdahl Round, CEO of Acarix Presents at Redeye Life Science Day 2022.

View
November 16, 2022

Acarix publishes Q3 2022 report.

View
September 26, 2022

Acarix and the American College of Cardiology announce strategic collaboration.

View
Fetching...

Latest Press Releases

See all press
  1. US user manual v.12.5, prevalence 10,7%, algorithm version US3.2
  2. Winther S, et al. Heart 2018;104:928–935 (Dan-NICAD I)
  3. Based on commercial patch use since 2017
*Rule-out with 96% confidence